120 related articles for article (PubMed ID: 38645409)
1. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2024; 12():1392532. PubMed ID: 38645409
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2022; 10():1009752. PubMed ID: 36225317
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2021; 9():765772. PubMed ID: 34858987
[TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p.
Wei L; Yang N; Sun L; Zhang L; Li Z; Li D; Qin T; Huang H
Transl Cancer Res; 2019 Sep; 8(5):2141-2150. PubMed ID: 35116964
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
Xu J; Xu Y; Ye G; Qiu J
J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG1 alleviates myocardial ischaemia-reperfusion injury by regulating the miR-137-3p/KLF4/TRPV1 axis.
Tang RF; Li WJ; Lu Y; Wang XX; Gao SY
ESC Heart Fail; 2024 Apr; 11(2):1009-1021. PubMed ID: 38234046
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of MicroRNA-21 Indicates Poor Prognosis and Promotes Cell Proliferation in Esophageal Squamous Cell Carcinoma via Upregulation of lncRNA SNHG1.
Luo D; Huang Z; Lv H; Wang Y; Sun W; Sun X
Cancer Manag Res; 2020; 12():1-14. PubMed ID: 32021418
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
11. SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.
Li J; Zhang Z; Xiong L; Guo C; Jiang T; Zeng L; Li G; Wang J
Biochem Biophys Res Commun; 2017 May; 487(1):146-152. PubMed ID: 28400279
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.
Ghafouri-Fard S; Abak A; Hussen BM; Taheri M; Sharifi G
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885097
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma.
Li X; Ma Z; Mei L
Aging (Albany NY); 2023 Aug; 15(15):7397-7407. PubMed ID: 37580802
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification.
Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
Front Cell Dev Biol; 2023; 11():1167476. PubMed ID: 37469575
[TBL] [Abstract][Full Text] [Related]
16. lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.
Gao Y; Zhang N; Lv C; Li N; Li X; Li W
J Alzheimers Dis; 2020; 77(1):85-98. PubMed ID: 32741808
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.
Zhou L; Zhang Q; Cheng J; Shen X; Li J; Chen M; Zhou C; Zhou J
Drug Discov Ther; 2023 Sep; 17(4):248-256. PubMed ID: 37599085
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():944740. PubMed ID: 35812444
[TBL] [Abstract][Full Text] [Related]
19. Biomarker Discovery for the Carcinogenic Heterogeneity Between Colon and Rectal Cancers Based on lncRNA-Associated ceRNA Network Analysis.
Qi X; Lin Y; Liu X; Chen J; Shen B
Front Oncol; 2020; 10():535985. PubMed ID: 33194594
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
Zhang N; Liu FL; Ma TS; Zhang ZZJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
